Multi-omics analysis reveals CLEC2A is a leukemia-restricted CART target in KMT2A-rearranged Acute Myeloid Leukemia

Danielle Kirkey(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Soheil Meshinchi(Fred Hutch Cancer Center)
Research Square
October 8, 2025
10.21203/rs.3.rs-7768680/v1
Cited by 0

Related Papers

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group
|Blood|2006|131
Children's Oncology Group's 2013 blueprint for research: Acute myeloid leukemia
|Pediatric Blood & Cancer|2012|83
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients
|Cancer|2013|75
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
|Leukemia|2023|52